Matthew J. Blecha
St. Joseph Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matthew J. Blecha.
Journal of Vascular Surgery | 2010
Thomas D. Willson; Elizabeth Revesz; Francis J. Podbielski; Matthew J. Blecha
Endofibrosis of the external iliac artery is an uncommon disease affecting primarily young, otherwise healthy, endurance athletes. Thigh pain during maximal exercise with quick resolution postexercise is characteristic of the so-called cyclists iliac syndrome. We report an unusual case in which the typical endofibrotic plaque was accompanied by dissection of the external iliac artery. The patient was treated surgically with excision of the affected artery segment and placement of an interposition graft. This case highlights an unusual finding in association with external iliac artery endofibrosis and provides an opportunity to briefly review the literature on the subject.
PLEURA | 2016
Francis J. Podbielski; Tracy E. Sambo; Arsalan Salamat; Matthew J. Blecha; Mark M. Connolly
Primary sarcoma of the lung and/or pleural cavity is a rare finding accounting for <0.5% of all thoracic malignancies. Histologically, mesothelioma predominates in this subcategory of neoplasms; its relationship to asbestos exposure and cigarette smoking is well documented. Other tumor types include fibrosarcoma, malignant fibrous histiocytoma, angiosarcoma, leiomyosarcoma, synovial sarcoma, and Ewing sarcoma. Standard evaluation with bronchoscopy and radiographically guided biopsy are frequently nondiagnostic and require open biopsy to provide an adequate tissue sample.
Vascular and Endovascular Surgery | 2012
Thomas D. Willson; Jason M. Korn; Matthew J. Blecha; Francis J. Podbielski; Mark M. Connolly
Hepatic artery aneurysms are the second most common visceral aneurysm but are still relatively uncommon. Over the last century, methods for treating these lesions have evolved substantially. The presented case covers the presentation, diagnosis, and treatment of a 65-year-old woman with an aneurysm of the intrahepatic portion of the hepatic artery. This case demonstrates the variety of techniques available for managing these lesions and the importance of both a thorough knowledge of the available treatments and the flexibility to switch among them when necessary.
Urology case reports | 2017
Jason Huang; Harpreet Wadhwa; Matthew J. Blecha; Paul Yonover
Ureterocutaneous fistulas are rare, often iatrogenic complications. We present a case of a 60 year old woman suffering a ureterocutaneous fistula in association with an infected vascular graft. Percutaneous diversion of urinary fluid with a nephrostomy tube is an acceptable form of management.
Journal of Gastrointestinal Cancer | 2013
Thomas D. Willson; Matthew J. Blecha; Mark M. Connolly; Francis J. Podbielski
Esophageal cancer is a less common malignancy of the gastrointestinal tract and continues to have a dismal prognosis despite screening programs for high-risk patients. Patients frequently present with advanced disease, and 5-year survival is 18.1 % on average [1]. Of esophageal cancers in the USA, 59 % are adenocarcinomas, while squamous cell lineages represent another 34.5 % [1]. Metastases are common at the time of presentation with 18–50 % of patients having distant or unresectable disease [1–3]. Despite poor overall survival, surgical resection remains a mainstay of curative therapy for esophageal cancer [4]. Most esophageal tumors are responsive to chemotherapy or combined chemoradiotherapy, and thus neoadjuvant therapy is recommended for patients with node-positive disease and those found to have T3 tumors on preoperative endoscopic ultrasonography. This treatment results in down-staging the primary tumor and eventual resection [2]. In practice, 40– 63 % of patients who undergo curative esophagectomy ultimately develop recurrence of their disease [4–7]. The median time to recurrence is 11–12 months [4, 5]. The pattern of esophageal cancer recurrence and metastasis is of interest given the emphasis on surgical treatment of these patients and the ongoing controversy as to whether an interventional approach to recurrence offers any survival benefit compared to symptomatic treatment [4, 5]. Visceral metastases and recurrences, including the kidney, are common [3, 6, 8–11]. Most metastases, however, are small, multiple, and bilateral [7, 9, 11, 12]. Solitary, isolated metastases from any cancer to the kidney are rare [12, 13]. There have been occasional reports of renal metastases from esophageal squamous cell carcinoma, but not from esophageal adenocarcinoma as is reported in this case [7, 9, 11, 14].
American Surgeon | 2007
Matthew J. Blecha; Elizabeth T. Clark; Todd A. Worley; Mario R. Salazar; Francis J. Podbielski
Journal of The American College of Surgeons | 2005
Matthew J. Blecha; Christos Galanopolous; Dilip Dharkar; George I. Salti
Jsls-journal of The Society of Laparoendoscopic Surgeons | 2006
Matthew J. Blecha; Frank Ar; Worley Ta; Francis J. Podbielski
Jsls-journal of The Society of Laparoendoscopic Surgeons | 2004
Francis J. Podbielski; Heron E. Rodriguez; Andrew M. Brown; Matthew J. Blecha; Mario R. Salazar; Mark M. Connolly
Journal of Vascular Surgery | 2018
Kira N. Long; Trissa Babrowski; Christopher L. Skelly; Matthew J. Blecha; Ross Milner